Cas 1338467-45-0,2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one

1338467-45-0

Post Buying Request

Basic information

Product Name: 2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one
Synonyms: 2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one
CAS NO:1338467-45-0
Molecular Formula:
Molecular Weight: 399.536
EINECS: N/A
Product Categories: N/A
Mol File: 1338467-45-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one(1338467-45-0)
EPA Substance Registry System: 2-butyl-5-((2,6-dimethyl-4-phenylpyridin-3-ylmethyl)amino)isoindolin-1-one(1338467-45-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1338467-45-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1338467-45-0 Suppliers

Recommended suppliersmore

1338467-45-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1338467-45-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,8,4,6 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1338467-45:
(9*1)+(8*3)+(7*3)+(6*8)+(5*4)+(4*6)+(3*7)+(2*4)+(1*5)=180
180 % 10 = 0
So 1338467-45-0 is a valid CAS Registry Number.

1338467-45-0Upstream product

1338467-45-0Downstream Products

1338467-45-0Relevant articles and documents

NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I

-

Page/Page column 27, (2011/10/13)

The present invention relates to small molecule potentiators of metabotropic receptors, in particular of the mGlu2 receptor. The present invention also relates to the use of these compounds for the prevention or treatment of neurological and psychiatric d

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1338467-45-0